Squalene Market by Source (Shark Liver, Vegetable, and Synthetic biotechnology), End-Use Industry (Skin Care, Hair Care, Fragrance, Food Supplements, and Healthcare) – Global Opportunity Analysis and Industry Forecast, 2014-2022
DescriptionSqualene Market by Source (Shark Liver, Vegetable, and Synthetic biotechnology), End-Use Industry (Skin Care, Hair Care, Fragrance, Food Supplements, and Healthcare) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Squalene is a natural oily liquid hydrocarbon found in plants and animals. Squalene is commonly found in large quantities in shark liver oil. It is the most common lipid produced by human skin cells, making up approximately 10 percent of our sebum. The rise in demand from different applications such as cosmetics and pharmaceuticals and its benefits on human health fuel the squalene market.
The global squalene market is anticipated to reach $214 million by 2022 compared to $110 million in 2015 growing at a CAGR of 10.1% during the forecast period. It is segmented based on source, end-use industry, and geography. The rise in awareness of its health benefits has resulted in the increased demand for squalene. Also, the steady rise in the cosmetics industry and increase in disposable income in developing countries such as China and India are responsible for the increase in demand for squalene in the region. In addition, it is used in health foods, vaccines, and as a high-grade machine lubricant.
Based on the source, squalene market is segmented as shark liver, vegetables, and synthetic biotechnology. Vegetable-sourced squalene is expected to be the fastest-growing segment due to its renewable nature, steady availability of raw material, and regulations regarding animal-sourced squalene.
Based on the end-use industry, squalene market is segmented as cosmetics, food supplements, and healthcare. Cosmetics industry dominated the squalene market in 2015, owing to the rise in awareness for using high quality products and willingness to pay premium prices for high quality products.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Europe led the market in 2015, and is anticipated to maintain this trend during the forecast period owing to vast potential that can be realized soon because of the growth of various end-use industries. The use of animal-sourced squalene dominates the Asia-Pacific market owing to high investments in the cosmetics end-use industry in China, Japan, and South Korea.
The companies profiled in the report include:
Arista Industries Inc.
Empressa Figueirrense de Pesca, LDA.
Kshimoto Special Liver Oil Co. Ltd.
New Zealand Green Health Ltd.
Maruha Nichiro Corporation
Seadragon Marine Oils Limited
Croda International PLC
KEY MARKET BENEFITS
This report provides an extensive analysis of the current trends, future estimations, and dynamics from 2014 to 2022 of the global squalene market, which assists to identify the prevailing opportunities.
Geographically, the market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
Exhaustive analysis predicts the applications that are currently used along with the variants that would gain prominence in the future.
Competitive intelligence of leading manufacturers and distributors highlights the competitive scenario across the geographies
Key market players are profiled and their strategies are analyzed thoroughly, which portrays the competitive outlook
KEY MARKET SEGMENTS:
Global Squalene Market is segmented as:
BY END-USE INDUSTRY
Rest of Europe
Rest of Asia-Pacific
Rest Of LAMEA
Table of ContentsCHAPTER 1 INTRODUCTION
1.1. Report description
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. Key findings
2.2. CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. key findings
3.2.1. Top investment pockets
3.3. Top Winning Strategies
3.4. Porters Five Forces Analysis
3.4.1. BARGAINING POWER OF SUPPLIERS
3.4.2. BARGAINING POWER OF BUYERS
3.4.3. THREAT OF SUBSTITUTES
3.4.4. THREAT OF NEW ENTRANTS
3.4.5. INTENSITY OF COMPETITIVE RIVALRY
3.4.6. Market dynamics
22.214.171.124. Growth of cosmetics industry
126.96.36.199. Increase in value and potential of dietary supplements
188.8.131.52. Squalene as a chemo-preventive agent
184.108.40.206. Government rules and regulations
220.127.116.11. Squalene as an antioxidant and immune system support
3.5. Product bench marking
3.6. patent analysis
CHAPTER 4 SQUALENE MARKET, BY SOURCE
4.2. Shark Liver
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. synthetic biotechnology
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 SQUALENE MARKET, BY END USE INDUSTRY
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
18.104.22.168. Skin care
22.214.171.124. Hair care
5.2.3. Market size and forecast
5.3. food supplements
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
126.96.36.199. Cancer treatment
188.8.131.52. Heart disease
184.108.40.206. Skin health
5.4.3. Market size and forecast
CHAPTER 6 SQUALENE MARKET, BY GEOGRAPHY
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.9. Rest of Europe
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.8. Rest of Asia-Pacific
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.7. Saudi Arabia
6.5.8. Rest of LAMEA
CHAPTER 7 COMPANY PROFILES
7.1. amyris, inc.
7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves and developments
7.2. Croda international plc
7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves and developments
7.3. seadragon marine oils limited
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments
7.4. Maruha nichiro corporation
7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.5. New Zealand Green Health Ltd.
7.5.1. Company overview
7.5.2. Operating business segments
7.6. Gracefruit limited
7.6.1. Company overview
7.6.2. Operating business segments
7.7. Kshimoto special liver oil co., ltd.
7.7.1. Company overview
7.7.2. Operating business segments
7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Key strategic moves and developments
7.9. Empresa figueirense de pesca, lda
7.9.1. Company overview
7.9.2. Operating business segments
7.10. Arista industries inc.
7.10.1. Company overview
7.10.2. Operating business segments
- Arista Industries Inc.
- Empressa Figueirrense de Pesca, LDA.
- Kshimoto Special Liver Oil Co. Ltd.
- Gracefruit Limited
- New Zealand Green Health Ltd.
- Maruha Nichiro Corporation
- Seadragon Marine Oils Limited
- Croda International PLC
- Amyris Inc.